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Abstract
Background: Influenza vaccination is recommended by the World Health Organization for high risk groups, yet few
data exist on influenza disease burden in West Africa.
Methods: We estimated medically attended influenza-associated illness rates among residents of Shai-Osudoku and
Ningo Pram-Pram Districts (SONPD), Ghana. From May 2013 to April 2015, we conducted prospective surveillance
for severe acute respiratory illness (SARI) and influenza-like illness (ILI) in 17 health facilities. In 2015, we conducted a
retrospective assessment at an additional 18 health facilities to capture all SONPD SARI and ILI patients during the
study period. We applied positivity rates to those not tested to estimate total influenza cases.
Results: Of 612 SARI patients tested, 58 (9%) were positive for influenza. The estimated incidence of
influenza-associated SARI was 30 per 100,000 persons (95% CI: 13-84). Children aged 0 to 4 years had the
highest influenza-associated SARI incidence (135 per 100,000 persons, 95% CI: 120-152) and adults aged 25
to 44 years had the lowest (3 per 100,000 persons, 95% CI: 1-7) (p < 0.01). Of 2,322 ILI patients tested, 407
(18%) were positive for influenza. The estimated incidence of influenza-associated ILI was 844 per 100,000
persons (95% CI: 501-1,099). The highest incidence of influenza-associated ILI was also among children aged
0 to 4 years (3,448 per 100,000 persons, 95% CI: 3,727 – 3,898). The predominant circulating subtype during
May to December 2013 and January to April 2015 was influenza A(H3N2) virus, and during 2014 influenza B
virus was the predominant circulating type.
Conclusions: Influenza accounted for 9% and 18% of medically attended SARI and ILI, respectively. Rates
were substantive among young children and suggest the potential value of exploring the benefits of
influenza vaccination in Ghana, particularly in this age group.
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Background
Influenza is an important contributor to acute respira-
tory infection (ARI) - a leading cause of morbidity, mor-
tality and economic loss worldwide [1]. A review of
seasonal influenza epidemiology in sub-Saharan Africa
found that 10% (range: 1%-25%) of outpatient acute re-
spiratory cases and 7% (range: 1%-16%) of children hos-
pitalized with ARI tested positive for influenza [2]. The
impact of seasonal and pandemic influenza could be
substantial in Africa due to the prevalence of other in-
fections and comorbidities that could increase the sever-
ity of influenza disease [3, 4]. During 2006 to 2010,
influenza surveillance capacity increased substantially in
sub-Saharan Africa [5]. There are now 24 World Health
Organization (WHO) designated National Influenza
Centers in Africa and 10 African countries regularly re-
port influenza surveillance data to the Global Influenza
Surveillance and Response System (GISRS) [6]. Despite
these advances, there are few data describing influenza
disease burden in West African countries.
During 2012 in Ghana, lower respiratory tract infections
were the leading cause of death [7]. In 2013, Noguchi Me-
morial Institute for Medical Research (NMIMR) of the
University of Ghana, Ghana Health Service and the U.S.
Centers for Disease Control & Prevention (CDC) estab-
lished health facility–based surveillance for influenza and
other respiratory viruses among residents of Shai-
Osudoku and Ningo-Prampram Districts (SONPD) in the
Greater Accra Region. The NMIMR serves as Ghana’s Na-
tional Influenza Centre (NIC). The Dodowa Health and
Demographic Surveillance System (HDSS), established in
2005, monitors the demographics of 121,943 residents [8]
of SONPD. Surveillance data indicate that influenza trans-
mission is year-long with peaks during the rainy seasons
although further surveillance to ascertain seasonality is
needed. The current immunization program does not in-
clude the use of seasonal influenza vaccines in Ghana. Fol-
lowing the 2009 influenza A(H1N1) pandemic, it became
clear that data on influenza were needed to guide public
health policies and actions to lessen the impact of influ-
enza on populations in West Africa. We present incidence
estimates of medically attended influenza in a rural peri-
urban area of Ghana through health facility-based pro-
spective and retrospective surveillance.
Methods
Surveillance sites
SARI and ILI Surveillance
In 2012, a health utilization survey (HUS) identified the
health facilities where SONPD residents frequently
sought care and this information was used to identify
the study surveillance sites [9]. Only residents of
SONPD were included in the study regardless of
whether the surveillance site was located in or outside
the SONPD. Patients with an HDSS identification num-
ber and/or a SONPD address were identified as a resi-
dent. In early 2013, we established prospective severe
acute respiratory illness (SARI) and influenza-like illness
(ILI) surveillance in nine health facilities: three hospitals,
three clinics and three community health centers. We
conducted SARI surveillance in the three hospitals and
ILI surveillance in all nine facilities, collecting both epi-
demiologic data and laboratory specimens from eligible
case-patients. Seven of these nine facilities were located
within SONPD and two were in adjacent districts
(Lower Manya District and North Tongu District). Al-
though the study period started in May 2013, prospect-
ive surveillance was established in March 2013. The two
months between the start of surveillance and the start of
the study period served to address operational mishaps
and ensure data quality.
The 2012 HUS identified another eight community
health centers in SONPD with very few (e.g., 1-10) pa-
tient visits per week. Due to their low patronage and re-
mote location, we collected epidemiologic data from
these eight ILI surveillance sites but did not collect la-
boratory specimens. Hence, there were a total 17 study
surveillance sites: 9 collecting both epidemiologic data
and laboratory specimens from eligible case-patients and
8 collecting epidemiologic data only from April 2013 to
May 2015.
Retrospective record review
In 2015, we conducted an assessment of the catchment
area and decided to perform a retrospective record re-
view of an additional 18 health facilities (14 inside and 4
outside SONPD) which had been part of the 2012 HUS
to capture all SARI and ILI patients for this study [9].
We reviewed consulting room registers, patient folders
and admission records for period May 2013 to April
2015 and captured all data electronically. Laboratory
specimens from these SARI and ILI patients were not
available for testing. Figure 1 depicts the geographic dis-
tribution of all of the healthcare facilities included in this
study and differentiates between sites where specimens
were collected and where only syndromic data were col-
lected. In all, nine hospitals were included in the study.
The 2012 HUS showed that >99% of SONPD residents
sought care at one of these hospitals.
Eligibility, consenting and recruitment
ILI was defined as a respiratory illness with history of
fever or measured axillary temperature ≥37.5 °C and
cough with onset within the last 10 days. The WHO rec-
ommended case definition for ILI does not include a his-
tory of fever [10]. SARI was defined as an ILI requiring
hospitalization. Eligible subjects were patients aged
≥1 month, resident of SONPD, who sought care at a
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study site and met one of the above case definitions. Pa-
tients aged <1 month were excluded because investiga-
tors felt it was culturally inappropriate to ask caregivers
for their participation in the study. Study staff were
present in the health facilities Monday through Friday
during business hours. Staff reviewed weekend and after
hour log books to identify all SARI and ILI patients. Pa-
tients who resided outside SONPD were excluded from
the study.
All eligible SARI and the first five eligible ILI patients
per site who provided consent were enrolled weekly. ILI
case enrolment began at the beginning of the week and
ended as soon as five patients had been enrolled irre-
spective of day of the week. Study staff explained the
risks and benefits of study participation to eligible par-
ticipants prior to enrolment. Participants who agreed to
be part of the study were asked to sign a written consent
form. For participants aged 5-17, parent/legal guardian
consent and participant assent were also obtained. For
participants aged <5 years, only parent/legal guardian
consent was obtained.
Ethical considerations
The surveillance protocol was reviewed and approved by
the scientific and technical committee and the institu-
tional review board of NMIMR (054/12-13). CDC granted
a non-research determination (NRD#2013 6261).
Data and specimen collection
Screening log books were used to record total attend-
ance as well as total number of ILI and SARI patients at
all 17 sites. Trained field staff, which included
physicians, nurses, midwives and research assistants,
used a structured questionnaire to capture clinical and
demographic information from enrolled participants
using a personal digital assistant (PDA) (Additional file
1: Figure SA). The age, gender, weight, date of illness on-
set, and date of visit were recorded for all SARI and ILI
patients identified. In addition, date of admission and
duration of hospitalization were recorded for SARI pa-
tients. Weight-for-age was calculated and categorized ac-
cording to the WHO Child Growth Standards [11]. Data
from PDAs were transferred electronically to a server at
NMIMR on a biweekly basis. Trained healthcare workers
collected nasopharyngeal and/or oropharyngeal swabs
from enrolled patients and placed them in a single vial
of transport medium (Becton Dickinson and Company,
Franklin Lakes, New Jersey, USA). Specimens were
transported within 24 hours in a cool box with ice packs
to the NIC. Depending on the time of day the specimens
arrived, they were either tested right away or frozen to
be tested later. Specimens that were not sent to the NIC
within 24 hours were stored on-site in liquid nitrogen
tanks and transferred to the NIC in cool boxes.
Virologic testing
Viral ribonucleic acid (RNA) was extracted using the
QIAamp® Viral RNA Mini Kit (Qiagen, Hilden,
Germany) according to manufacturer’s recommenda-
tions. Influenza virus was detected using standardized
real-time reverse-transcription polymerase chain reac-
tion (rRT-PCR) protocols from CDC (13). The rRT-PCR
assays were performed with AgPath One-Step rRT-PCR
kit (Thermo Fisher Scientific, Inc., Waltham,
Fig. 1 Map of Ghana and geographic distribution healthcare facilities in which virologic and/or syndromic surveillance were conducted to assess the
burden of medically attended influenza among residents of Shai-Osudoku and Ningo-Prapram districts, May 2013- April 2015. Image attribution: By
Thfc - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=20018233
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Massachusetts, USA) on the Applied Bios systems 7500
fast rRT-PCR instrument (Thermo Fisher Scientific, Inc.,
Waltham, Massachusetts, USA).
Data analyses
Annual incidence rates were calculated using population
denominators obtained from the HDSS [8]. Residents
are enumerated in the HDSS annually and we used the
population for year 2014. We estimated the number of
influenza cases among those not tested by multiplying
the percent positive among those tested by the number
not tested; we did this first by using age-group specific
positivity rates and second by age-group and month-
specific positivity rates. The age groups used were 0 to
4, 5 to 14, 15 to 24, 25 to 44, 45 to 64 and >65 years.
This same age grouping is used in the HDSS. We esti-
mated rates of influenza-associated SARI and ILI by
adding the numbers testing positive to those estimated
to be positive among non-tested and dividing by the
population. We calculated the 95% confidence intervals
(lower and upper limits) for the proportion of patients
tested with influenza-positive specimens and applied
these to those who were not tested. The group referred
to as “not tested” from this point forward includes all
SONPD residents who were identified as SARI or ILI pa-
tients during the study period but did not have a labora-
tory specimen for influenza testing either because they
were identified through the retrospective record review
or during the prospective routine surveillance but were
not tested for other reasons. The age group 0-4 years
was not adjusted for the exclusion of infants <1 month
because there were no population estimates for infants
aged <1 month.
We calculated medians, interquartile ranges and rates
with associated 95% confidence intervals using Microsoft
Excel© (Microsoft Corporation, Redmond, WA). We cal-
culated crude odds ratios and used the Wilcoxon Rank
Sum test to compare medians in SAS version 9.3 (SAS
Institute, Cary, NC) and used Fisher and mid-p exact
tests to compare rates in OpenEpi (Dean AG, Sullivan
KM, Soe MM., Emory University, Atlanta, GA). Results
were considered statistically significant if the associated
two-sided p-value was <0.05.
Results
Study population
Between May 1, 2013 through April 30, 2015, there were
801 SARI patients among SONPD residents, 612 (76%)
of which were tested for influenza. Approximately half
(292/612) had a history of fever but no recorded
temperature documenting a fever. The median age of
SARI patients tested was 3 years (interquartile range
[IQR]: 1-9 years) while that of SARI patients not tested
was 9 years (IQR: 2-30 years) (p < 0.01) (Table 1).
Patients were not tested because they were admitted
and/or discharged on weekends or afterhours (n = 68,
36%), sought care at a facility that did not offer testing
(n = 50, 27%) refused consent (n = 45, 24%), or were crit-
ically ill (n = 21, 11%) (Fig. 2). The median duration of
hospitalization among SARI patients tested was 7 days
(IQR: 3-9 days) and among SARI patients who were not
tested was 1 day (IQR: 1-2 days) (Table 1).
Of 11,866 eligible SONPD residents with ILI, 2,322
(20%) were tested. Half (52%) had a history of fever but
no recorded temperature documenting a fever. The me-
dian age of ILI patients tested was 3 years (IQR: 1-12
years) while that of ILI patients not tested was 2 years
(IQR: 0-10 years) (p <0.01). The median number of days
between onset of symptoms and seeking medical care
among ILI patients tested was 3 (IQR: 2-4 days) and
among ILI patients who were not tested was 3 (IQR: 1-
3) (Table 1).
Virologic testing
Of 612 SARI patients tested, 58 (9%) were positive for
influenza viruses. Among the influenza-positive cases, 31
(54%) were identified as influenza A(H3N2) virus, 14
(24%) as influenza A(H1N1) pdm09 virus, and 13 (22%)
as influenza B virus. The median age of SARI patients
testing positive for influenza was 4 years (IQR: 1-12
years) and of SARI patients testing negative for influenza
was 3 years (IQR: 1-9 years) (p =0.02). Among hospital-
ized children aged 1 to 4 years, those who tested positive
for influenza were more likely to be low weight-for-age
than children who were influenza-negative (odds ratio:
3.3, 95% confidence interval [CI]: 1.3-10.3, p = 0.04).
Of 2,322 ILI patients tested, 407 (18%) were positive
for influenza viruses; of these, 196 (48%) were influenza
A(H3N2) virus, 53 (13%) influenza A(H1N1) pdm09
virus, and 158 (39%) influenza B virus. The median age
of ILI patients testing positive for influenza was 5 years
(IQR: 2-13 years) and of ILI patients testing negative for
influenza was 3 years (IQR: 1-12 years) (p < 0.01). Al-
though the predominant circulating subtype during May
to December 2013 and January to April 2015 was influ-
enza A(H3N2) virus, influenza B virus was the predom-
inant circulating type during 2014. During 24 months of
surveillance, there were influenza-positive specimens in
23 months (Fig. 3).
Incidence of influenza-associated SARI and ILI
The incidence of influenza-associated SARI was 30 per
100,000 persons (95% CI: 13 to 84). The annual inci-
dence was highest among children aged 0 to 4 years
(135 per 100,000 persons, 95% CI: 120-152) and dropped
to a low among adults aged 25 to 44 years (3 per
100,000 persons, 95% CI: 1-7) (p < 0.01) before rising
slightly to 28 per 100,000 persons (95% CI: 21-36)
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among those >65 years of age. The rate of influenza-
associated SARI among all ages during the first year of
the study (28 per 100,000 persons, 95% CI: 10-87) was
similar to the second year of the study (32 per 100,000
persons, 95% CI: 16-81) (p = 0.61) (Table 2).
The incidence of influenza-associated ILI was 844 per
100,000 persons (95% CI: 501-1,099). Children 0 to
4 years of age had the highest incidence of medically
attended influenza-associated ILI (3,811 per 100,000 per-
sons, 95% CI: 3,727-3,898). During the first year of the
study, the rate of medically attended influenza-
associated ILI was higher (1,080 per 100,000 persons,
95% CI: 707-1,367) than during the second year (608 per
100,000 persons, 95% CI: 296-831) (p < 0.01) (Table 2).
Discussion
The incidence of influenza-associated hospitalizations
and outpatient visits was highest among children aged 0
to 4 years in SONPD from May 2013 to April 2015. This
is consistent with Nair et al.’s finding that the global bur-
den of illness attributable to influenza in young children
is substantial [12]. A study in South Africa found that
children aged <1 year and adults aged >75 years had the
highest rates of influenza-associated respiratory
hospitalization estimated at 255 per 100,000 person-
years and 380 per 100,000 person-years, respectively
[13]. Similarly, Emukule et al. estimated the annual inci-
dence of hospitalized influenza-associated SARI among
children aged <5 years in Kenya to be between 180 and
390 cases per 100,000 person-years [14].
Influenza circulated year-round in the districts during
the study period; this is consistent with studies summar-
izing influenza surveillance data from West Africa [5, 8].
During the 24 month study period, the primary circulat-
ing subtype in SONPD was influenza A(H3N2) virus.
For this same time period, WHO’s GISRS reported influ-
enza A(H3N2) virus as the predominant subtype circu-
lating in West Africa based upon data received from
Ghana and 5 other West African countries [6]. A sum-
mary of global circulation of influenza viruses using data
from 85 countries found that tropical settings, like
Ghana, have year-round influenza activity more often
than temperate and subtropical sites [15]. While
influenza-associated SARI rates were similar for both
study years, the rates of medically attended influenza-
associated ILI varied significantly by year. Although the
reason for this variation is unknown, it could be that this
is representative of the true burden of influenza illness
or a reflection of year-to-year variability in health-care
seeking behavior due to availability of public services or
changes in the local economy.
Our study only assessed medically attended SARI and
ILI. We have no doubt underestimated the true inci-
dence of influenza-associated illness in this community
because we did not measure non-medically attended ILI
or SARI. Although we used the 2012 HUS to select the
Table 1 Characteristics of influenza-like illness (ILI) and severe acute respiratory illness (SARI) patients in Shai-Osudoku and Ningo-
Prampram Districts, May 2013 – April 2015
ILI SARI
Tested (N = 2,322) Not tested (N = 9,544) Influenza-positive Tested (N = 612) Not tested (N = 189) Influenza-positive
Age group, years (n, %) <0.01
0 to 4 1,355 (58) 5,161 (54) 203 (15) 386 (63) 74 (37) 32 (8)
5 to 14 433 (19) 2,026 (21) 108 (25) 108 (18) 28 (14) 14 (13)
15 to 24 163 (7) 677 (7) 36 (22) 27 (4) 26 (13) 4 (15)
25 to 44 231 (10) 979 (10) 41 (18) 49 (8) 31 (16) 1 (2)
45 to 64 100 (4) 440 (5) 15 (15) 30 (5) 21 (11) 5 (17)
≥65 40 (2) 261 (3) 4 (10) 12 (2) 19 (10) 2 (17)
Influenza-positive (n, %) 407 (18) 58 (9)
Duration of symptoms
prior to seeking health
care-daysa
Median 3 3 2 0




Median NA NA 7 1
Interquartile Range NA NA 3-9 1-2
aMissing data: ILI Tested = 51%, ILI Not tested = 23%, SARI Tested = 1 record missing 0%, SARI Not tested = 6%
bMissing data: SARI Tested = 5%, SARI Not tested = 20%
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study sites and are confident to have captured close to
all medically attended SARI, we have less certainty about
having captured all medically attended ILI among
SONPD residents. A study comparing hospitalized
influenza-associated SARI rates to non-hospitalized in-
fluenza-associated SARI rates highlighted the import-
ance of healthcare seeking behaviour when calculating
influenza-associated disease burden estimates, particu-
larly in low and middle-income countries [16]. More-
over, although the elderly are at greater risk for
influenza-associated complications and hospitalizations
[17], we found that persons >65 years had rates of
influenza-associated SARI similar to other adults,
though our numbers were very small. This outcome
may be due to various healthcare access barriers faced
by the elderly despite Ghana’s National Health Insur-
ance Scheme which exempts them from paying an-
nual premiums [18]. We also decided to exclude
infants <1 month old in our study. This limits the
findings for age group aged 0-5 years, likely under-
estimating the true burden of influenza illness among
the very young. Although prospective surveillance was
Fig. 2 Total severe acute respiratory illness (SARI) patients identified and tested in Shai-Osudoku and Ningo-Prampram Districts (SONDP), May
2013 – April 2015
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conducted at a number of surveillance sites, we relied
on review of medical records and registers to assess
SARI and ILI in sites where we did not conduct pro-
spective surveillance. It is possible that incomplete re-
cording of fever, cough or duration of symptoms
could have reduced detection of patients meeting the
surveillance case definition.
This study describes the burden of medically
attended influenza-associated illness in a population
with continuous demographic surveillance. In some
instances, age-group and month specific positivity
rates were unstable because of small numbers. Using
a 2-sided significance level likely underestimated
variability, leading to narrow confidence intervals.
Our methods applied the proportion influenza-
positive among those tested to those not tested in
order to estimate the total number of influenza cases
by age-group. ILI cases were systematically sampled
to limit potential bias between those tested and not
tested. There were, however, statistically significant
differences in the median ages of tested versus non-
tested groups among SARI and ILI patients. This is a
study limitation because there is no way to know if
this resulted in an over- or under-estimation of the
true burden of disease. In addition, more data are
needed to estimate the burden of influenza-associated
illness among high-risk groups, including pregnant
women, those aged 0-6 months and HIV-infected in-
dividuals. We are currently conducting separate stud-
ies in SONPD to address some of these data gaps.
Fig. 3 Distribution of influenza virus types and subtypes among influenza like illness (ILI) and severe acute respiratory illness (SARI) patients in
Shai-Osudoku and Ningo-Prampram Districts, May 2013 - April 2015
Table 2 Estimated annual incidence of influenza-associated influenza-like illness (ILI) and severe acute respiratory illness (SARI) in
Shai-Osudoku and Ningo-Prampram Districts, May 2013 – April 2015
Incidence of influenza-associated ILI and SARI (95% CI)
Number of cases per 100,000 persons Population denominatorb
ILI SARI
Overall (agea) 895 (854- 937) 33 (26 – 42) 121,943
Overall (age-month┼) 844 (501 – 1099) 30 (13 – 84)
Age Group (agea)
0 to 4 years 3,811 (3,727 – 3,898) 135 (120– 152) 12,807
5 to 14 years 1,026 (983 – 1,071) 30 (23 – 39) 29,888
15 to 24 years 356 (331 – 383) 16 (12 – 23) 26,049
25 to 44 years 327 (303 – 353) 3 (1 – 7) 32,865
45 to 64 years 285 (263 – 309) 33 (26 – 42) 14,205
≥65 years 246 (225 –268) 28 (21 – 36) 6,129
Year of Study (agea)
Year 1 (May 2013 – April 2014) 1080 (707 - 1367) 28 (10 - 87)
Year 2 (May 2014 – April 2015) 608 (296 – 831) 32 (16 - 81)
Number positive among those not tested determined using age-groupa or age-group-month┼ specific positivity rates among those tested (see Methods)
bPopulation for year 2014 (Dodowa Health and Demographic Surveillance System)
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Conclusions
In this population in Ghana, influenza-associated ILI
and SARI has the highest burden among children aged 0
to 4 years. More data are needed to improve influenza
disease burden estimates, including estimating non-
hospitalised severe influenza-associated illness by age,
especially in the elderly and specific high-risk groups.
Our findings suggest the value of modelling the number
of cases and costs that could be averted through influ-
enza vaccination of high-risk target groups identified by
the WHO.
Additional file
Additional file 1: Figure SA. Enrolment process for severe acute
respiratory illness (SARI) and influenza like illness (ILI) in Shai-Osudoku and
Ningo-Prampram Districts, Ghana, 2013-2015. (DOCX 34 kb)
Abbreviations
ARI: Acute respiratory infection; CDC: U.S. Centers for Disease Control
and Prevention; CI: Confidence interval; GISRS: Global Influenza
Surveillance and Response System; HDSS: Health and Demographic
Surveillance System; HUS: Health utilization survey; ILI: Influenza-like
illness; IQR: Interquartile range; NIC: National Influenza Centre;
NMIMR: Noguchi Memorial Institute for Medical Research; NRD:
Non-research determination; PDA: Personal digital assistant; RNA: Viral
ribonucleic acid; rRT-PCR: Real-time reverse-transcription polymerase
chain reaction; SARI: Severe acute respiratory illness; SONPD:
Shai-Osudoku and Ningo Pram-Pram Districts; WHO: World Health
Organization
Acknowledgements
Noguchi Memorial Institute for Medical Research, University of Ghana: Wilma
Appiah, Gloria Odame-Asiedu, Yaa Serwaa Karikari, Ekua Houphouet, Kofi
Bonney, Ivy Asante, Elijah Edu-Quansah, Nana Afia Asante-Ntim, Gifty Mawuli,
Naa Dedei Aryeequaye, James Aboagye, Collins Addae, Ernestina Agbenyo,
Kwabena Boateng and Joyce Appiah-Kubi.
Ghana Health Service: Badu Sarkodie, Margaret Gyapong, Kennedy Brightson,
Gabriel Attipoe-Djagmah, Arnold Osei-Wusu, Afua Animwaa Asante, Gifty
Ofori-Ansah, Esi Therson-Cofie, Evelyn Ansah, Benedicta Owusu Appiah,
Moses Drah, Humphrey Lartey, Justice Amissah, Joseph Orion, Orlando Fofoe,
Abubakar Abdul Karim, Jemima Osei, Philip Diameh, Sefakor Homuame and
Patience Padi.
U.S. Centers for Disease Control and Prevention: Eduardo Azziz-Baumgartner
and Jerome Tokars.
Funding
This study was funded by the United States Department of Health and
Human Services, U.S. Centers for Disease Control and Prevention (CDC),
Award Number: U011P000607-04. The findings and conclusions in this report
are those of the authors and do not necessarily represent the view of the
CDC.
Availability of data and materials
Materials described in the manuscript, including all relevant raw data, will be
freely available to any scientist wishing to use them for non-commercial pur-
poses, without breaching participant confidentiality, upon request and pend-
ing institutional approval processes.
Authors’ contributions
MN, JD, MM, JF, PP, EB, TN, MA, ED, MW, FD, KK and WA conceived of the
study and participated in its design, including the writing of the protocol.
MN, JA, PP, EB, TN, EB, MA, WA carried out field work by doing one or more
of the following: collecting/analysing data, testing specimens, coordinating
sites and training study personnel. MN, JD, MM, MW, KK and WA contributed
substantially to the writing of the manuscript. All authors read and approved
the final manuscript.
Competing interests
The authors declared that they have no competing interests.
Consent for publication
I, Jazmin Duque, have read the Editorial policy and confirm that all authors
have given their permission to publish and that I will attach these consents
in a separate document.
Ethics approval and consent to participate
The manuscript contains a sub-heading titled "ethical considerations" which
gives the name of the ethics committees that reviewed this study and the
appropriate reference numbers. The manuscript contains a sub-heading titled
"eligibility, consenting and recruitment" which explains the consenting of
study subjects.
Author details
1Noguchi Memorial Institute for Medical Research, University of Ghana, Accra,
Ghana. 2Battelle Atlanta, Atlanta, Georgia, USA. 3Influenza Division, National
Center for Immunization and Respiratory Diseases, U.S. Centers for Disease
Control and Prevention, 1600 Clifton Rd NE, MS-A32, Atlanta, GA 30329, USA.
4U.S. Public Health Service, Rockville, Maryland, USA. 5CTS Global Inc, El
Segundo, California, USA. 6Ghana Health Service, Accra, Ghana.
Received: 21 June 2016 Accepted: 29 November 2016
References
1. WHO. The global burden of disease: 2004 update. Geneva: World Health
Organization; 2008.
2. Gessner BD, Shindo N, Briand S. Seasonal influenza epidemiology in sub-Saharan
Africa: a systematic review. Lancet Infect Dis. 2011;11(3):223–35.
3. Ortiz JR, Lafond KE, Wong TA, Uyeki TM. Pandemic influenza in Africa,
lessons learned from 1968: a systematic review of the literature. Influenza
Other Respir Viruses. 2012;6(1):11–24.
4. Brammer L, Budd A, Cox N. Seasonal and pandemic influenza surveillance
considerations for constructing multicomponent systems. Influenza Other
Respir Viruses. 2009;3(2):51–8.
5. Radin JM, Katz MA, Tempia S, Talla Nzussouo N, Davis R, Duque J, Adedeji A,
Adjabeng MJ, Ampofo WK, Ayele W, et al. Influenza surveillance in 15
countries in Africa, 2006-2010. J Infect Dis. 2012;206 Suppl 1:S14–21.
6. Global Influenza Surveillance and Response System [http://www.who.int/
influenza/gisrs_laboratory/en/]. Accessed 14 Sept 2015.
7. WHO. Ghana: WHO statistical profile; 2012.
8. Dodowa Health Research Center. 2016.
9. Adjabeng M: Report on utlization of health facilities by residents of the
Dangme West District. Edited by Research NMIfM 2012
10. WHO. A manual for estimating disease burden associated with seasonal
influenza. Geneva: World Health Organization; 2015.
11. The WHO child growth standards [http://www.who.int/childgrowth/en/].
Accessed 9 Sept 2015.
12. Nair H, Brooks WA, Katz M, Roca A, Berkley JA, Madhi SA, Simmerman JM,
Gordon A, Sato M, Howie S, et al. Global burden of respiratory infections
due to seasonal influenza in young children: a systematic review and meta-
analysis. Lancet. 2011;378(9807):1917–30.
13. Kyeyagalire R, Tempia S, Cohen AL, Smith AD, McAnerney JM, Dermaux-
Msimang V, Cohen C. Hospitalizations associated with influenza and
respiratory syncytial virus among patients attending a network of private
hospitals in South Africa, 2007-2012. BMC Infect Dis. 2014;14:694.
14. Emukule GO, Khagayi S, McMorrow ML, Ochola R, Otieno N, Widdowson
MA, Ochieng M, Feikin DR, Katz MA, Mott JA. The burden of influenza and
RSV among inpatients and outpatients in rural western Kenya, 2009-2012.
PLoS One. 2014;9(8):e105543.
15. Azziz Baumgartner E, Dao CN, Nasreen S, Bhuiyan MU, Mah EMS, Al Mamun A,
Sharker MA, Zaman RU, Cheng PY, Klimov AI, et al. Seasonality, timing, and
climate drivers of influenza activity worldwide. J Infect Dis. 2012;206(6):838–46.
16. Fuller JA, Summers A, Katz MA, Lindblade KA, Njuguna H, Arvelo W, Khagayi S,
Emukule G, Linares-Perez N, McCracken J, et al. Estimation of the national
Ntiri et al. BMC Infectious Diseases  (2016) 16:757 Page 8 of 9
disease burden of influenza-associated severe acute respiratory illness in Kenya
and Guatemala: a novel methodology. PLoS One. 2013;8(2):e56882.
17. D'Mello T, Brammer L, Blanton L, Kniss K, Smith S, Mustaquim D, Steffens C,
Dhara R, Cohen J, Chaves SS, et al. Update: Influenza activity–United States,
September 28, 2014-February 21, 2015. MMWR Morb Mortal Wkly Rep. 2015;
64(8):206–12.
18. Parmar D, Williams G, Dkhimi F, Ndiaye A, Asante FA, Arhinful DK, Mladovsky
P. Enrolment of older people in social health protection programs in West
Africa–does social exclusion play a part? Soc Sci Med. 2014;119:36–44.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Ntiri et al. BMC Infectious Diseases  (2016) 16:757 Page 9 of 9
